News | September 26, 2011

Elekta Demonstrates Radiation Therapy Systems at ASTRO

September 26, 2011 — Elekta will highlight several of its radiation therapy products at the American Society for Therapeutic Radiology and Oncology (ASTRO) annual meeting Oct. 2-6 in Miami Beach, Fla.

During the meeting, the company will feature two solutions in particular: Clarity with Autoscan real-time soft tissue tracking and the Identify radiofrequency identification (RFID)-based solution.

Clarity with Autoscan uses non-ionizing ultrasound technology to continuously track prostate anatomy during simulation and treatment without requiring additional non-therapeutic radiation dose. Unlike other technologies, it does not require invasive implants; images are acquired by placing a probe against the patient's perineum, minimizing any interference or collision risks with the treatment machine. This enables clear visualization of target and critical structure location at any time during treatment delivery and facilitates high precision treatments. As an automated, user-independent imaging technique, the system provides real-time soft tissue tracking without negative impact on treatment times or clinical workflow.

Identify is designed to ensure patient safety in the clinic and increase staff confidence in the reliability of patient identification and accessories. The system employs advanced RFID technology to ensure the right patient is being treated at the right location and with the correct set up and equipment. Identify is integrated with Elekta's Mosaiq Oncology Information System, enabling patient queuing, automatic opening of patient charts and treatment tracking at the EMR, optimizing workflow and safety.

The Elekta exhibit will also feature a live theater at which speakers will give hourly presentations on the company’s solutions, including Identify and Clarity with Autoscan.

   For more information: www.elekta.com

Related Content

RayStation Selected for New Carbon Ion Therapy Center in Japan
News | Treatment Planning | January 18, 2018
January 18, 2018 – RayStation has been chosen as the treatment planning system for a new carbon-ion therapy facility
Raysearch Receives First Order for the Raycare Oncology Information System
News | Oncology Information Management Systems (OIMS) | January 18, 2018
January 18, 2018 – Anderson Regional Cancer Center (ARCC) in Meridian, Mississippi, has placed the first order for...
Mevion Receives 510(k) Clearance for Hyperscan Pencil Beam Scanning Proton Therapy
Technology | Proton Therapy | January 04, 2018
Mevion Medical Systems has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the Mevion S250i...
Study Compares Radiosurgery and Whole-Brain Radiation in Lung Cancer Patients With Multiple Brain Metastases
News | Radiation Therapy | January 03, 2018
Although targeted therapies have produced dramatic advances in the ability to control some types of advanced lung...
MEDraysintell Downgrades Proton Therapy Market Projection for 2030
News | Proton Therapy | January 02, 2018
MEDraysintell recently downgraded its projection for proton therapy rooms expected to be operational in 2030 from 1,200...
California US Oncology Network Centers Adopt Xoft Electronic Brachytherapy System for Early-Stage Non-Melanoma Skin Cancer
News | Brachytherapy Systems | January 02, 2018
iCAD Inc. announced that its Xoft Axxent Electronic Brachytherapy (eBx) System is now available at two California-based...
Blue Phantom System Used for Acceptance of First European Varian Halcyon Machine
News | Radiation Therapy | January 02, 2018
IBA (Ion Beam Applications S.A.) announced in November the acceptance and beam model validation of the first Varian...
Study Finds Link Between Breast Cancer Treatments and Cellular Aging Markers
News | Women's Health | January 02, 2018
January 2, 2018 — A new study found women who had received chemotherapy and/or...
ACR Appropriateness Criteria Adds and Revises Topics for December 2017
News | Clinical Decision Support | December 29, 2017
December 29, 2017 — Radiologists can enhance the quality and effectiveness of care with the newest release of the ACR
FDA Clears GammaPod Stereotactic Radiotherapy System for Breast Cancer Treatment
Technology | Stereotactic Body Radiation Therapy (SBRT) | December 22, 2017
The U.S. Food and Drug Administration (FDA) has cleared the new GammaPod noninvasive stereotactic radiotherapy system...
Overlay Init